Drugs / LiveSpo Smile CARE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07258303 | Dec 2025 → Oct 2026 expected | mouth disorder, periodontal disorder | Anabio R&D | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LiveSpo Smile CARE | “Participants assigned to the experimental group will receive LiveSpo® Smile CARE (20 mL), formulated as an oral-spray probiotics containing ≥ 1 × 10⁹ CFU/ mL of Bacillus...” NCT07258303 ↗ |
| Modality | Other / unclassified | “a oral-spray Bacillus spore probiotics (LiveSpo Smile CARE)” NCT07258303 ↗ |
| Route | Oral | “The suspension will be self-administered via oral spray twice daily once in the afternoon and once at night.” NCT07258303 ↗ |